Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. companies react cautiously to Trump victory

Published 11/09/2016, 03:32 PM
Updated 11/09/2016, 03:32 PM
© Reuters. A poster is displayed on the floor NYSE the morning after the U.S. presidential election in New York

By Noel Randewich

SAN FRANCISCO (Reuters) - U.S. companies reacted on Wednesday with caution to businessman Donald Trump's victory in the U.S. presidential election and pointed to uncertainty over his lack of clear policy proposals.

A smattering of analyst conference calls held by companies reporting their quarterly results offered a glimpse of how they view the country's new path led by the former reality TV host.

Following campaign promises by Trump to renegotiate global trade agreements and make U.S. companies move factories back to the United States, over 1,100 manufacturers and businesses offered in an open letter on Wednesday to work with him.

"We will look for areas upon which we agree and can work productively with your new administration," said the letter, which was signed by companies including Caterpillar (N:CAT) and Boeing (N:BA).

Magellan Health (O:MGLN), a healthcare management company, noted in a call after its report that Trump promised to do away with President Barack Obama's signature Affordable Care Act.

"We think it will have an impact, clearly, on our business here," Chief Executive Barry Smith said. "We don't have any details of his proposals and the process by which they will be enacted, but we will hopefully know more in the coming weeks and months here."

HMS Holdings (O:HMSY), another healthcare manager, also posted quarterly results above analysts' expectations but its stock slumped 17 percent.

"There hasn't been any real policy that we can react to at this point," HMS Holdings CEO Bill Luci said, addressing the election result.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sucampo Pharmaceuticals (O:SCMP) jumped as much as 31 percent after the biopharmaceutical company raised its full-year sales forecast.

It was among several pharmaceutical companies rallying following months of promises by Democratic candidate Hillary Clinton to regulate drug prices.

"Obviously Hillary Clinton's agenda was much more well-articulated," said Chief Executive Officer Peter Greenleaf. "I will be interested to see what we learn as Mr. Trump takes office and we learn more about what his agenda is going to be for the industry."

In its quarterly call, EV Energy Partners LP (O:EVEP) said it and other oil and natural gas producers stand to benefit from reduced regulation under Trump.

"My concern, obviously, is Trump himself, whether or not he will be presidential and whether he can control his ego. My major concern, specifically, will be Mexico because it's such an important ally," said Executive Chairman John Walker.

Trump has vowed to build a wall on the U.S.-Mexico border to keep out immigrants.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.